ReviewFrontiers in oncology2021

Ocular Toxicity of Belantamab Mafodotin, an Oncological Perspective of Management in Relapsed and Refractory Multiple Myeloma.

Ahsan Wahab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.